Pharmacy practice of clinical pharmacists involved in the treatment of a case of bullous pemphigoid and pulmonary aspergillosis combined with disseminated Nocardia farcinica infection
|更新时间:2024-08-23
|
Pharmacy practice of clinical pharmacists involved in the treatment of a case of bullous pemphigoid and pulmonary aspergillosis combined with disseminated Nocardia farcinica infection
DENG Tiying,LIN Min,HU Zhimin,et al.Pharmacy practice of clinical pharmacists involved in the treatment of a case of bullous pemphigoid and pulmonary aspergillosis combined with disseminated Nocardia farcinica infection[J].ZHONGGUO YAOFANG,2024,35(16):2038-2043.
DENG Tiying,LIN Min,HU Zhimin,et al.Pharmacy practice of clinical pharmacists involved in the treatment of a case of bullous pemphigoid and pulmonary aspergillosis combined with disseminated Nocardia farcinica infection[J].ZHONGGUO YAOFANG,2024,35(16):2038-2043. DOI: 10.6039/j.issn.1001-0408.2024.16.18.
Pharmacy practice of clinical pharmacists involved in the treatment of a case of bullous pemphigoid and pulmonary aspergillosis combined with disseminated Nocardia farcinica infection
To provide a reference for the adjustment of antibacterial drug regimens, identification of adverse reactions, and personalized pharmaceutical care for patients with bullous pemphigoid and pulmonary aspergillosis combined with disseminated
Nocardia farcinica
infection.
METHODS
2
Clinical pharmacists participated in the entire treatment process of a patient with bullous pemphigoid and pulmonary aspergillosis combined with disseminated
N. farcinica
infection. Evidence-based medicine was used to assist in the selection of an initial combined drug regimen against nocardiosis, and time
ly communication with the microbiology laboratory to provide early antimicrobial susceptibility data. When the patient exhibited epilepsy, the suspected drugs were identified, and it was reminded that imipenem-cilastatin sodium could affect the efficacy of valproic acid. It was suggested to replace valproic acid with levetiracetam for anti-epileptic treatment and to discontinue imipenem-cilastatin sodium. During treatment, it was recommended to monitor the blood concentrations of voriconazole and linezolid, and assist in adjusting the dosage promptly based on the monitoring results.
RESULTS
2
The physicians accepted the recommendations of the clinical pharmacists. The patient’s condition improved, and they were discharged with medication.
CONCLUSIONS
2
Based on evidence-based medical evidence, antimicrobial susceptibility test results, and blood concentration monitoring data, clinical pharmacists assist clinicians in selecting a sensitive anti-infective regimen for the patient, identifying adverse reactions, adjusting the treatment regimen and providing full-course medication monitoring to ensure the safety and efficacy of clinical drug therapy.
关键词
皮疽诺卡菌感染大疱性类天疱疮肺曲霉病癫痫临床药师药学监护
Keywords
bullous pemphi-goidpulmonary aspergillosisepilepsyclinical pharmacistpharmaceutical care
references
HAMDI A M,FIDA M,DEML S M,et al. Retrospective analysis of antimicrobial susceptibility profiles of Nocardia species from a tertiary hospital and reference laboratory,2011 to 2017[J]. Antimicrob Agents Chemother,2020,64(3):e01868-e01819.
HUANG L,CHEN X C,XU H P,et al. Clinical features,identification,antimicrobial resistance patterns of Nocardia species in China:2009-2017[J]. Diagn Microbiol Infect Dis,2019,94(2):165-172.
CLARK N M,REID G E,AST Infectious Diseases Community of Practice. Nocardia infections in solid organ transplantation[J]. Am J Transplant,2013,13(Suppl. 4):83-92.
DENG T Y,HU Z M,XU Q,et al. Clinical pharmaceu-tical practice of constructing mind map by clinical pharmacists for the consultation of pulmonary nocardiosis[J]. China Pharm,2023,34(15):1899-1903.
YE X F,ZHANG J Q,JIN M L. Pharmaceutical care of anti-infection medication of 1 patient with lupus erythematosus and Nocardia by clinical pharmacists:“two point theory” and “key point theory” in drug therapy[J]. Shanghai Med Pharm J,2020,41(21):71-75.
GKRINIA E,BIZAKI-VALLASKANGAS A,RAUTIAINEN M,et al. Nocardia farcinica mastoiditis and epidural abscess in an immunocompetent patient:a rare entity[J/OL]. Ear Nose Throat J,2022[2024-01-03].https://journals.sagepub.com/doi/10.1177/01455613221139400?url_ver= Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub% 20%200pubmedhttps://journals.sagepub.com/doi/10.1177/01455613221139400?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed. DOI:10.1177/01455613221139400http://dx.doi.org/10.1177/01455613221139400.
MAO Y Y,CHEN L,WENG H. Clinical features of 25 cases of pulmonary nocardiosis[J]. Chin J Infect Chemother,2020,20(6):613-617.
WEI M,WANG P,QU J X,et al. Identification and antimicrobial susceptibility of clinical Nocardia species in a tertiary hospital in China[J]. J Glob Antimicrob Resist,2017,11:183-187.
CHEN K,ZHANG X L,KE X Y,et al. Individualized medication of voriconazole:a practice guideline of the division of therapeutic drug monitoring,Chinese Pharmacological Society[J]. Ther Drug Monit,2018,40(6):663-674.
HAMADA Y,UEDA T,MIYAZAKI Y,et al. Effects of antifungal stewardship using therapeutic drug monitoring in voriconazole therapy on the prevention and control of hepatotoxicity and visual symptoms:a multicentre study conducted in Japan[J]. Mycoses,2020,63(8):779-786.
Special Committee of Infectious Diseases,Chinese Association of Medicine Education. Expert consensus on the clinical application of pharmacokinetic/pharmacodynamic theory of antimicrobial agents[J]. Chin J Tuberc Respir Dis,2018,41(6):409-446.
DU X,LI X Y,XIE X H,et al. Effects of carbapenems on plasma concentrations of valproic acid and influencing factors of seizures after a combined usage of carbapenems and valproic acid:literature meta-analysis[J]. Chin J Hosp Pharm,2021,41(4):395-399.
WANG Y Y,YU J H,ZHAO L P,et al. Effects of three carbapenems on the plasma concentration of sodium valproate in patients with severe infection complicated with epilepsy due to liver insufficiency and its solutions[J]. Chin Gen Pract,2021,24(Suppl. 1):52-54.
RIVERO A,GARCÍA-LÁZARO M,PÉREZ-CAMACHO I,et al. Successful long-term treatment with linezolid for disseminated infection with multiresistant Nocardia farcinica[J]. Infection,2008,36(4):389-391.
LIN B,HU Y M,XU P,et al. Expert consensus statement on therapeutic drug monitoring and individualization of linezolid[J]. Front Public Health,2022,10:967311.
TRIFILIO S M,YARNOLD P R,SCHEETZ M H,et al. Serial plasma voriconazole concentrations after allogeneic hematopoietic stem cell transplantation[J]. Antimicrob Agents Chemother,2009,53(5):1793-1796.